Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Treatment of Gastroesophageal Reflux Disease in 12-16 Year Old Patients With Rabeprazole

ClinicalTrials.gov ID: NCT00132496

Public ClinicalTrials.gov record NCT00132496. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 9:27 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Safety and Efficacy of Rabeprazole in the Treatment of Gastroesophageal Reflux Disease in 12-16 Year Old Patients

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of this study is to collect safety information on rabeprazole 10 mg and 20 mg in the treatment of gastroesophageal reflux disease (GERD) in children aged 12 to 16 years. The secondary objectives are to assess the efficacy of rabeprazole on the improvement of the symptoms of GERD and to explore the relationship of symptom relief to dose received, based on symptom frequency and severity, antacid use, and quality of life (QOL) measures.

Study identification

NCT ID
NCT00132496
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Eisai Inc.
Industry
Enrollment
111 participants

Conditions and interventions

Eligibility (public fields only)

Age range
12 Years to 16 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 2005 (Type not available)
Primary completion
May 2006 (Actual)
Completion
Jul 2006 (Actual)
Last update posted
Dec 3, 2009

2005 – 2006

United States locations

U.S. sites
25
U.S. states
16
U.S. cities
24
Facility City State ZIP Site status
Longmont Medical Research Network Longmont Colorado 80501 —
Nova Southeastern University Fort Lauderdale Florida 33328 —
Babies and Beyond Peds New Port Richey Florida 34652 —
Dr. Patricia Barrington, Dr. B. Abraham, PC Snellville Georgia 30039 —
Multi-specialty Clinical Research Hoffman Estates Illinois 60194 —
Kentucky Pediatric/Adult Research Bardstown Kentucky 40004 —
Professional Clinical Research Cadillac Michigan 49601 —
Community Pediatric Associates Kalamazoo Michigan 49008 —
The Center for Human Nutrition Omaha Nebraska 68105 —
Children's Hospital of Buffalo - Digestive Disease And Nutrition Center Buffalo New York 14222 —
Winthrop University Hospital Mineola New York 11501 —
Pediatric Associates of Mount Carmel, Inc. Cincinnati Ohio 45245 —
Pediatric Associates of Mt. Carmel Cincinnati Ohio 45245 —
University of Pediatrics Mason Ohio 45040 —
Center for Children's Digestive Health Youngstown Ohio 44514 —
Pharmacotherapy Research Associates Zanesville Ohio 43701 —
Biomedical Research Associates Shippensburg Pennsylvania 17257 —
DeGarmo Institute of Medicine Research Greer South Carolina 29651 —
Focus Research Group Hendersonville Tennessee 37075 —
ProMed Healthcare Johnson City Tennessee 37601 —
NE Ohio University College of Medicine Lebanon Tennessee 37087 —
Southwest Children's Research Associates San Antonio Texas 78229 —
Alpine Medical Group Salt Lake City Utah 84102 —
Rockwood Clinic North Spokane Washington 99202 —
Marshall University Huntington West Virginia 25701 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00132496, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 3, 2009 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00132496 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →